Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT02465515 · COMPLETED
Trial details
- NCT number
- NCT02465515
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-02-20
- Enrollment
- 9463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.